End Stage Kidney Disease
Conditions
Brief summary
The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.
Detailed description
In a single site, 2-arm (Social Virtual Reality group; Individual Virtual Reality Group), parallel, randomized controlled trial we will enroll 60 subjects (n=30 per group) to assess the effects of Social Virtual Reality to Individual Virtual Reality on symptoms in participants with end stage kidney disease who are receiving hemodialysis. To compare the effects of social virtual reality to individual virtual reality on loneliness To explore the effects of social virtual reality to individual virtual reality on anxiety and depression. To compare the effects social virtual reality to individual virtual reality on quality of life.
Interventions
BEHAVIORALSocial Virtual Reality
Participants interact using virtual reality during dialysis.
BEHAVIORALIndividual Virtual Reality
Participants use virtual reality alone during dialysis.
Sponsors
University of Pennsylvania
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Diagnosis of end stage kidney disease with hemodialysis 3 times per week for at least 1 month
Exclusion criteria
* Acutely ill * Active nausea * Epilepsy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| De Jong Gierveld Scale | Baseline and 4 Weeks | Measures how bad or severe a person's loneliness is. Score range from 11-44; higher scores indicate more loneliness. |
Countries
United States
Contacts
CONTACTLea Ann Matura, PhD
PRINCIPAL_INVESTIGATORLea Ann Matura, PhD
University of Pennsylvania
Outcome results
None listed